Lyudmila Tsurkan

1.8k total citations
21 papers, 1.0k citations indexed

About

Lyudmila Tsurkan is a scholar working on Pharmacology, Molecular Biology and Computational Theory and Mathematics. According to data from OpenAlex, Lyudmila Tsurkan has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 10 papers in Molecular Biology and 8 papers in Computational Theory and Mathematics. Recurrent topics in Lyudmila Tsurkan's work include Cholinesterase and Neurodegenerative Diseases (16 papers), Computational Drug Discovery Methods (8 papers) and Enzyme function and inhibition (5 papers). Lyudmila Tsurkan is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (16 papers), Computational Drug Discovery Methods (8 papers) and Enzyme function and inhibition (5 papers). Lyudmila Tsurkan collaborates with scholars based in United States, Canada and Israel. Lyudmila Tsurkan's co-authors include Philip M. Potter, Janice L. Hyatt, Carol C. Edwards, M. Jason Hatfield, Monika Wierdl, Mary K. Danks, Randy M. Wadkins, Matthew R. Redinbo, Christopher L. Morton and Michael R. Taylor and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Lyudmila Tsurkan

21 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lyudmila Tsurkan United States 18 499 382 241 193 161 21 1.0k
Janice L. Hyatt United States 23 672 1.3× 628 1.6× 423 1.8× 396 2.1× 221 1.4× 27 1.5k
M. Jason Hatfield United States 18 635 1.3× 353 0.9× 189 0.8× 204 1.1× 352 2.2× 27 1.4k
Pierre Ducrot France 20 707 1.4× 171 0.4× 365 1.5× 335 1.7× 128 0.8× 34 1.3k
Raku Shinkyo Japan 20 545 1.1× 216 0.6× 91 0.4× 51 0.3× 170 1.1× 29 1.2k
Daniel P. Walker Australia 16 510 1.0× 164 0.4× 174 0.7× 267 1.4× 142 0.9× 49 1.3k
Timothy W. Harper United States 17 345 0.7× 177 0.5× 65 0.3× 192 1.0× 104 0.6× 30 1.0k
Ahmed H.E. Hassan Egypt 23 449 0.9× 200 0.5× 118 0.5× 444 2.3× 185 1.1× 89 1.2k
Xuewei Wu China 15 693 1.4× 127 0.3× 84 0.3× 463 2.4× 212 1.3× 28 1.3k
Carmela Gnerre Switzerland 18 288 0.6× 254 0.7× 81 0.3× 374 1.9× 234 1.5× 39 1.1k
Cyril Ronco France 20 565 1.1× 541 1.4× 376 1.6× 510 2.6× 167 1.0× 45 1.3k

Countries citing papers authored by Lyudmila Tsurkan

Since Specialization
Citations

This map shows the geographic impact of Lyudmila Tsurkan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyudmila Tsurkan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyudmila Tsurkan more than expected).

Fields of papers citing papers by Lyudmila Tsurkan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyudmila Tsurkan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyudmila Tsurkan. The network helps show where Lyudmila Tsurkan may publish in the future.

Co-authorship network of co-authors of Lyudmila Tsurkan

This figure shows the co-authorship network connecting the top 25 collaborators of Lyudmila Tsurkan. A scholar is included among the top collaborators of Lyudmila Tsurkan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lyudmila Tsurkan. Lyudmila Tsurkan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wierdl, Monika, Lyudmila Tsurkan, Liying Chi, et al.. (2018). Targeting ALK in pediatric RMS does not induce antitumor activity in vivo. Cancer Chemotherapy and Pharmacology. 82(2). 251–263. 7 indexed citations
2.
Gutova, Margarita, Leanne Goldstein, Marianne Z. Metz, et al.. (2016). Optimization of a Neural Stem-Cell-Mediated Carboxylesterase/Irinotecan Gene Therapy for Metastatic Neuroblastoma. Molecular Therapy — Oncolytics. 4. 67–76. 17 indexed citations
3.
Wierdl, Monika, Lyudmila Tsurkan, M. Jason Hatfield, & Philip M. Potter. (2016). Tumour‐selective targeting of drug metabolizing enzymes to treat metastatic cancer. British Journal of Pharmacology. 173(19). 2811–2818. 4 indexed citations
4.
Hatfield, M. Jason, Robyn A. Umans, Janice L. Hyatt, et al.. (2016). Carboxylesterases: General detoxifying enzymes. Chemico-Biological Interactions. 259(Pt B). 327–331. 129 indexed citations
5.
Hatfield, M. Jason, Lyudmila Tsurkan, Janice L. Hyatt, et al.. (2013). Modulation of Esterified Drug Metabolism by Tanshinones from Salvia miltiorrhiza (“Danshen”). Journal of Natural Products. 76(1). 36–44. 56 indexed citations
6.
Lynch, J.A., Yao Wang, Yu Fukuda, et al.. (2012). ATP-dependent Mitochondrial Porphyrin Importer ABCB6 Protects against Phenylhydrazine Toxicity. Journal of Biological Chemistry. 287(16). 12679–12690. 54 indexed citations
7.
Tsurkan, Lyudmila, M. Jason Hatfield, Carol C. Edwards, Janice L. Hyatt, & Philip M. Potter. (2012). Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors. Chemico-Biological Interactions. 203(1). 226–230. 48 indexed citations
8.
Parkinson, Elizabeth I., M. Jason Hatfield, Lyudmila Tsurkan, et al.. (2011). Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-diones. Bioorganic & Medicinal Chemistry. 19(15). 4635–4643. 20 indexed citations
9.
Hemmert, Andrew, Tamara C. Otto, Roberto A. Chica, et al.. (2011). Nerve Agent Hydrolysis Activity Designed into a Human Drug Metabolism Enzyme. PLoS ONE. 6(3). e17441–e17441. 13 indexed citations
10.
Tsurkan, Lyudmila, et al.. (2010). Biochemical and molecular analysis of carboxylesterase‐mediated hydrolysis of cocaine and heroin. British Journal of Pharmacology. 160(8). 1916–1928. 51 indexed citations
11.
Hatfield, M. Jason, Lyudmila Tsurkan, Michael R. Garrett, et al.. (2010). Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11. Biochemical Pharmacology. 81(1). 24–31. 75 indexed citations
12.
Wierdl, Monika, Lyudmila Tsurkan, Janice L. Hyatt, et al.. (2008). An improved human carboxylesterase for enzyme/prodrug therapy with CPT-11. Cancer Gene Therapy. 15(3). 183–192. 43 indexed citations
13.
Hyatt, Janice L., Randy M. Wadkins, Lyudmila Tsurkan, et al.. (2007). Planarity and Constraint of the Carbonyl Groups in 1,2-Diones Are Determinants for Selective Inhibition of Human Carboxylesterase 1. Journal of Medicinal Chemistry. 50(23). 5727–5734. 34 indexed citations
14.
Hyatt, Janice L., M. Jason Hatfield, Lyudmila Tsurkan, et al.. (2007). Selective Inhibition of Carboxylesterases by Isatins, Indole-2,3-diones. Journal of Medicinal Chemistry. 50(8). 1876–1885. 60 indexed citations
15.
Hyatt, Janice L., Carol C. Edwards, Lyudmila Tsurkan, et al.. (2007). Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils. Bioorganic & Medicinal Chemistry. 15(11). 3801–3817. 37 indexed citations
16.
Danks, Mary K., Karina J. Yoon, Joanna S. Remack, et al.. (2007). Tumor-Targeted Enzyme/Prodrug Therapy Mediates Long-term Disease-Free Survival of Mice Bearing Disseminated Neuroblastoma. Cancer Research. 67(1). 22–25. 114 indexed citations
17.
Wadkins, Randy M., Janice L. Hyatt, Carol C. Edwards, et al.. (2006). Analysis of Mammalian Carboxylesterase Inhibition by Trifluoromethylketone-Containing Compounds. Molecular Pharmacology. 71(3). 713–723. 34 indexed citations
18.
Hyatt, Janice L., Lyudmila Tsurkan, Monika Wierdl, et al.. (2006). Intracellular inhibition of carboxylesterases by benzil: modulation of CPT-11 cytotoxicity. Molecular Cancer Therapeutics. 5(9). 2281–2288. 41 indexed citations
19.
Fleming, Christopher D., Sompop Bencharit, Carol C. Edwards, et al.. (2005). Structural Insights into Drug Processing by Human Carboxylesterase 1: Tamoxifen, Mevastatin, and Inhibition by Benzil. Journal of Molecular Biology. 352(1). 165–177. 122 indexed citations
20.
Hyatt, Janice L., Lyudmila Tsurkan, Christopher L. Morton, et al.. (2005). Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11. Chemico-Biological Interactions. 157-158. 247–252. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Janice L. Hyatt Breakdown of academic impact, for papers by M. Jason Hatfield Breakdown of academic impact, for papers by Pierre Ducrot Breakdown of academic impact, for papers by Raku Shinkyo Breakdown of academic impact, for papers by Daniel P. Walker Breakdown of academic impact, for papers by Timothy W. Harper Breakdown of academic impact, for papers by Ahmed H.E. Hassan Breakdown of academic impact, for papers by Xuewei Wu Breakdown of academic impact, for papers by Carmela Gnerre Breakdown of academic impact, for papers by Cyril Ronco
Rankless by CCL
2026